Vanda Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Vanda Pharmaceuticals Inc
TickerVNDA
CIK #0001347178
CUSIP921659108
SectorLife Sciences - Pharmaceutical Preparations
Address9605 Medical Center Drive Suite 300, Rockville, MD 20850
Source [EDGAR]
CIK Filing 2011 - 2026
[0001347178] 10-K
[0001347178] 10-Q
[0001347178] 3
[0001347178] 4
[0001347178] 5
[0001347178] 8-K
[0001347178] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Vanda Pharmaceuticals Inc [2026-05-12] 0.0
Millennium Management LLC Vanda Pharmaceuticals Inc [2025-07-01] 0.0
BlackRock Portfolio Management LLC Vanda Pharmaceuticals Inc [2025-04-15] 0.0
Dimensional Fund Advisors LP Vanda Pharmaceuticals Inc [2023-02-10] 5.0
State Street Corp Vanda Pharmaceuticals Inc [2021-02-11] 5.86
BlackRock Inc Vanda Pharmaceuticals Inc [2021-01-25] 17.9
Renaissance Technologies LLC Vanda Pharmaceuticals Inc [2020-02-12] 6.47
Armistice Capital LLC Vanda Pharmaceuticals Inc [2019-06-24] 6.2
Consonance Capital Management LP Vanda Pharmaceuticals Inc [2019-02-14] 8.53
Macquarie Group Ltd Vanda Pharmaceuticals Inc [2018-02-14] 5.02
Vanguard Group Inc Vanda Pharmaceuticals Inc [2018-02-09] 6.3
Armistice Capital LLC Vanda Pharmaceuticals Inc [2017-06-19] 5.1
Great Point Partners LLC Vanda Pharmaceuticals Inc [2017-02-17] 5.04
Point72 Asset Management LP Vanda Pharmaceuticals Inc [2017-02-16] 5.0
Integrated Core Strategies US LLC Vanda Pharmaceuticals Inc [2016-01-27] 4.3
Great Point Partners LLC Vanda Pharmaceuticals Inc [2016-01-15] 5.45
Stonepine Capital Management LLC Vanda Pharmaceuticals Inc [2015-07-02] 5.5
Armistice Capital LLC Vanda Pharmaceuticals Inc [2015-03-27] 5.5
Paulson & Co Inc Vanda Pharmaceuticals Inc [2015-02-17] 0.14
Flynn James E Vanda Pharmaceuticals Inc [2014-08-01] 6.09
Price T Rowe Associates Inc /MD/ Vanda Pharmaceuticals Inc [2014-07-10] 10.1
Palo Alto Investors LLC Vanda Pharmaceuticals Inc [2014-02-14] 0.8
Kingdon Capital Management LLC Vanda Pharmaceuticals Inc [2014-02-14] 6.75
FMR LLC Vanda Pharmaceuticals Inc [2013-12-10] 0.0
Integrated Core Strategies US LLC Vanda Pharmaceuticals Inc [2013-10-11] 2.7
Baker Bros Advisors LLC Vanda Pharmaceuticals Inc [2013-06-10] 14.0
Palo Alto Investors LLC Vanda Pharmaceuticals Inc [2013-02-14] 5.1
First Eagle Investment Management LLC Vanda Pharmaceuticals Inc [2013-02-11] 6.77
[2012-12-10] None
Tang Capital Partners LP Vanda Pharmaceuticals Inc [2012-04-20] 6.9
Form 3/4/5 Filer 2011 - 2026
Honore Tage
Vanda Pharmaceuticals Inc
Dugan Richard W
McGuire Daniel Patrick
Chrousos Phaedra
Duncan Charles Cliff
Ward Anne Sempowski
Mitchell Stephen Ray
Howell Scott Laverne
Polymeropoulos Christos Vasilios Mihael
Williams Timothy
Birznieks Gunther
Polymeropoulos Mihael Hristos
Moran Kevin Patrick
Wijkstrom Joakim
Watkins Thomas
Jones Aranthan II
Reverberi Gian Piero
Kelly James Patrick
Cola Michael F
Milano Vincent
Gulino Richard L
Bate Kenneth
Baroldi Paolo
Deerfield Special Situations Fund LP
Deerfield Management Company LP
Deerfield Capital LP
Deerfield International Master Fund LP
Deerfield Partners LP
Flynn James E
Pien Howard H
Gibbs Thomas Edward
Deerfield Special Situations International Master Fund LP
Galson Steven K
Repella Robert
Feeney John Joseph
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Wijkstrom Joakim
Common Stock
2026-03-02 Sell 30,800 $8.27 254,716
Moran Kevin Patrick
Common Stock
2026-03-02 Sell 42,442 $8.27 350,995
Williams Timothy
Common Stock
2026-03-02 Sell 42,434 $8.27 350,929
Polymeropoulos Mihael Hristos
Common Stock
2026-03-02 Sell 156,235 $8.17 1,276,440
Birznieks Gunther
Common Stock
2026-03-02 Sell 42,431 $8.27 350,904
Honore Tage
Common Stock
2026-02-23 Sell 30,000 $8.03 240,900
Moran Kevin Patrick
Common Stock
2026-02-18 Grant 125,000 $0.00
Polymeropoulos Mihael Hristos
Common Stock
2026-02-18 Grant 525,000 $0.00
Birznieks Gunther
Common Stock
2026-02-18 Grant 125,000 $0.00
Williams Timothy
Common Stock
2026-02-18 Grant 125,000 $0.00
Wijkstrom Joakim
Common Stock
2026-02-18 Grant 125,000 $0.00
Polymeropoulos Mihael Hristos
Common Stock
2025-08-07 Buy 10,000 $4.15 41,500
Mitchell Stephen Ray
Common Stock
2025-06-13 Sell 7,000 $4.59 32,130
Mitchell Stephen Ray
Common Stock
2025-06-05 Grant 59,225 $0.00
Chrousos Phaedra
Common Stock
2025-06-05 Grant 59,225 $0.00
Ward Anne Sempowski
Common Stock
2025-06-05 Grant 59,225 $0.00
Honore Tage
Common Stock
2025-06-05 Grant 59,225 $0.00
Dugan Richard W
Common Stock
2025-06-05 Grant 59,225 $0.00
Polymeropoulos Mihael Hristos
Common Stock
2025-05-21 Buy 481 $4.39 2,112
Polymeropoulos Mihael Hristos
Common Stock
2025-05-21 Buy 9,519 $4.40 41,884
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 170 44,836,323
2025-12-31 156 40,701,567
2025-09-30 150 43,213,696
2025-06-30 140 44,244,925
2025-03-31 148 42,777,724
2024-12-31 148 41,406,968
2024-09-30 153 42,438,199
2024-06-30 152 43,635,724
2024-03-31 145 49,433,220
2023-12-31 159 51,662,590
2023-09-30 180 50,535,526
2023-06-30 189 55,111,050
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 294,131 294,131
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 3,732 97,400
Merit Financial Group LLC [2026-06-30] OTR 0 21,473
NorthCrest Asset Manangement LLC [2026-06-30] SOLE 594 12,946
Eastern Bank [2026-06-30] SOLE 5,000 5,000
Merit Financial Group LLC [2026-06-30] SOLE 47 4,694
Farther Finance Advisors LLC [2026-06-30] SOLE 0 2,979
IFP Advisors LLC [2026-06-30] SOLE 2,543 2,543
Versant Capital Management Inc [2026-06-30] SOLE 2,417 2,417
True Wealth Design LLC [2026-06-30] SOLE 0 1,327
Gamma Investing LLC [2026-06-30] DFND 290 290
Fortitude Family Office LLC [2026-06-30] SOLE 65 65
CGC Financial Services LLC [2026-06-30] SOLE 0 50
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 5
GHP Investment Advisors Inc [2026-06-30] SOLE 4 4
Hughes Financial Services LLC [2026-06-30] SOLE 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com